A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 196,114 shares of IONS stock, worth $7.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
196,114
Previous 199,231 1.56%
Holding current value
$7.16 Million
Previous $9.5 Million 17.26%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$40.06 - $51.86 $124,867 - $161,647
-3,117 Reduced 1.56%
196,114 $7.86 Million
Q2 2024

Jul 19, 2024

SELL
$36.45 - $47.7 $766,543 - $1 Million
-21,030 Reduced 9.55%
199,231 $9.5 Million
Q1 2024

Apr 19, 2024

SELL
$42.03 - $53.55 $1.35 Million - $1.72 Million
-32,198 Reduced 12.75%
220,261 $9.55 Million
Q4 2023

Jan 30, 2024

SELL
$43.39 - $51.63 $1.74 Million - $2.07 Million
-40,014 Reduced 13.68%
252,459 $12.8 Million
Q3 2023

Oct 30, 2023

SELL
$38.5 - $47.13 $140,871 - $172,448
-3,659 Reduced 1.24%
292,473 $13.3 Million
Q2 2023

Jul 31, 2023

SELL
$34.73 - $43.33 $46,434 - $57,932
-1,337 Reduced 0.45%
296,132 $12.2 Million
Q1 2023

Apr 27, 2023

SELL
$33.58 - $41.2 $1.32 Million - $1.62 Million
-39,263 Reduced 11.66%
297,469 $10.6 Million
Q4 2022

Jan 30, 2023

SELL
$37.12 - $46.52 $3.73 Million - $4.67 Million
-100,444 Reduced 22.98%
336,732 $12.7 Million
Q3 2022

Oct 21, 2022

SELL
$36.54 - $48.66 $1.13 Million - $1.51 Million
-30,940 Reduced 6.61%
437,176 $19.3 Million
Q2 2022

Jul 26, 2022

SELL
$31.71 - $43.0 $4.17 Million - $5.65 Million
-131,500 Reduced 21.93%
468,116 $17.3 Million
Q1 2022

Apr 27, 2022

SELL
$29.88 - $37.04 $187,825 - $232,833
-6,286 Reduced 1.04%
599,616 $22.2 Million
Q4 2021

Feb 02, 2022

SELL
$25.61 - $35.1 $2.04 Million - $2.8 Million
-79,758 Reduced 11.63%
605,902 $18.4 Million
Q3 2021

Oct 25, 2021

BUY
$33.54 - $40.55 $5.41 Million - $6.54 Million
161,334 Added 30.77%
685,660 $23 Million
Q2 2021

Aug 02, 2021

SELL
$34.54 - $47.25 $13 Million - $17.8 Million
-376,975 Reduced 41.83%
524,326 $20.9 Million
Q1 2021

Apr 30, 2021

BUY
$42.51 - $63.78 $5.81 Million - $8.71 Million
136,617 Added 17.87%
901,301 $40.5 Million
Q4 2020

Feb 05, 2021

BUY
$45.3 - $60.27 $1.17 Million - $1.56 Million
25,867 Added 3.5%
764,684 $43.2 Million
Q3 2020

Oct 30, 2020

SELL
$47.45 - $62.95 $2.21 Million - $2.93 Million
-46,612 Reduced 5.93%
738,817 $35.1 Million
Q2 2020

Jul 27, 2020

SELL
$46.85 - $61.05 $6.36 Million - $8.29 Million
-135,758 Reduced 14.74%
785,429 $46.3 Million
Q1 2020

Apr 27, 2020

SELL
$41.6 - $63.4 $2.04 Million - $3.11 Million
-48,996 Reduced 5.05%
921,187 $43.6 Million
Q4 2019

Jan 31, 2020

BUY
$53.85 - $65.27 $5.64 Million - $6.84 Million
104,720 Added 12.1%
970,183 $58.6 Million
Q3 2019

Oct 31, 2019

BUY
$59.06 - $72.15 $3.57 Million - $4.36 Million
60,363 Added 7.5%
865,463 $51.9 Million
Q2 2019

Jul 29, 2019

BUY
$62.09 - $86.14 $39.1 Million - $54.2 Million
629,275 Added 357.9%
805,100 $51.7 Million
Q1 2019

May 08, 2019

BUY
$52.92 - $81.17 $9.3 Million - $14.3 Million
175,825 New
175,825 $14.3 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.